IPHARMA CRO

IPHARMA, the partner of Skolkovo Innovative Center, is a fast-growing CRO in Russia and EAEU. Our mission is to contribute to progress of treating patients with socially significant and other important diseases by efficient organization of clinical studies and introduction of novel drugs to medical practice. Our pipeline consists of over 150 clinical studies in various therapeutic areas including oncology, HIV, HCV, diabetes, bronchial asthma, rheumatoid arthritis, schizophrenia, Alzheimers disease and many others. We provide efficient clinical trial solutions in both early-phase and registration studies, as well as medical, regulatory, and PV expertise to ensure optimal timeline for your drug...

Cro,gcp,phase 1,phase 2,phase 3,translational,poc,registration,viral infections,russia,oncology,endocrinology,cardiovascular,autoimmune disease,psychiatry,neurology,bioequivalence,biosimilars,therapeutic equivalence,patient recruitment,and russia and eaeu countries

Ipharma cro operates in the Pharmaceutical manufacturing industry.

Ipharma cro's revenue is 11m - 100m

Ipharma cro has 51 - 200 employees.